the present study indicated that KHDRBS3 could regulate BTB permeability through the cDENND4C/miR-577 axis, which enhanced doxorubicin delivery across BTB.
KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C/miR-577 axis.